DAVIS GREGORY D (Head of Research & Technology) received a stock award from SANGAMO THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0001415889-25-005708
Officer· Head of Research & Technology
Since Feb 2026
+147.97K
Net shares
Net buyer
$1.2K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
149.18K acquired · 1.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−705.00
Price / share
$1.00
Trade value
$705.00
% of position
0.4%
2/24/2025
167.57K→166.87K
Common Stock
Direct
Shares
−507.00
Price / share
$0.96
Trade value
$484.74
% of position
0.3%
2/25/2025
166.87K→166.36K
Common Stock
Direct
Shares
+49.73K
Price / share
—
Trade value
—
% of position
29.9%
2/25/2025
166.36K→216.08K
Total
Net shares
+48.51K
Net value
-$1.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | F · Tax Withholding | −705.00 | $1.00 | $705.00 | 0.4% | 167.57K | 166.87K |
| Common Stock Direct | 2/25/2025 | F · Tax Withholding | −507.00 | $0.96 | $484.74 | 0.3% | 166.87K | 166.36K |
| Common Stock Direct | 2/25/2025 | A · Award | +49.73K | — | — | 29.9% | 166.36K | 216.08K |
| Total | +48.51K | -$1.19K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
99.45K shares
Shares
+99.45K
Strike price
0.9561
Held after
99.45K
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock99.45K shares | 2/25/2025 | A · Award | +99.45K | 0.9561 | — | 99.45K |